This provider's $3.8M in total Medicare payments ranks in the 95th percentile of Ophthalmology providers nationally.
Medicare payments to this provider grew 19758% from 2017 to 2023.
AI-generated analysis based on Medicare payment data.
Notable: Payments increased 469% in 2019
Year-over-year payment surges can indicate changes in practice volume, new services, or billing pattern shifts.
Average per-service amounts submitted by the provider compared to what Medicare actually paid — the gap represents the markup.
| Year | Avg Submitted | Avg Paid | Markup Ratio | Gap per Service | Total Payments | Services | Beneficiaries |
|---|---|---|---|---|---|---|---|
| 2017 | $350.00 | $53.52 | 6.54x | $296.48 | $5.6K | 114 | 98 |
| 2018 | $442.03 | $114.91 | 3.85x | $327.12 | $29.9K | 476 | 376 |
| 2019 | $498.80 | $110.48 | 4.51x | $388.32 | $169.8K | 1.8K | 1.5K |
| 2020 | $762.15 | $189.05 | 4.03x | $573.10 | $727.3K | 4.9K | 2.9K |
| 2021 | $679.82 | $160.07 | 4.25x | $519.75 | $856.5K | 5.9K | 3.2K |
| 2022 | $484.42 | $113.91 | 4.25x | $370.51 | $930.2K | 7.2K | 3.2K |
| 2023 | $1.2K | $336.08 | 3.49x | $836.17 | $1.1M | 7.0K | 3.4K |
| Code | Description | Services | Payments | Avg/Service | Markup |
|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | 2.1K | $1.5M | $716.71 | 3.49x |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | 4.8K | $500.6K | $105.12 | 3.15x |
| 67028 | Injection of drug into eye | 4.7K | $460.8K | $98.33 | 5.49x |
| J2778 | Injection, ranibizumab, 0.1 mg | 1.5K | $351.2K | $233.38 | 4.28x |
| J3590 | Unclassified biologics | 121 | $262.8K | $2.2K | 3.07x |
| 92134 | Diagnostic imaging of retina | 6.9K | $238.0K | $34.71 | 12.21x |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | 902 | $120.5K | $133.64 | 3.10x |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | 1.1K | $120.3K | $111.35 | 2.35x |
| J3490 | Unclassified drugs | 29 | $53.7K | $1.9K | 2.98x |
| Q5128 | Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg | 237 | $51.3K | $216.55 | 4.62x |
| 92202 | Extended examination of eye with drawing of optic nerve and surrounding area (macula) | 2.4K | $32.6K | $13.55 | 5.92x |
| 92235 | Imaging of blood vessels in back of eye using fluorescein dye | 239 | $24.6K | $102.78 | 3.28x |
| J7999 | Compounded drug, not otherwise classified | 322 | $22.1K | $68.75 | 9.81x |
| 92201 | Extended examination of eye with drawing of retina | 1.0K | $21.4K | $21.03 | 4.18x |
| 67108 | Repair of detached retina and drainage of eye fluid between lens and retina | 13 | $13.9K | $1.1K | 3.53x |
| 92250 | Photography of the retina | 286 | $9.2K | $32.09 | 5.83x |
| 92012 | Eye and medical examination for diagnosis and treatment, established patient | 129 | $8.9K | $69.09 | 3.14x |
| 92004 | Eye and medical examination for diagnosis and treatment, new patient, 1 or more visits | 72 | $7.0K | $97.52 | 4.65x |
| 67145 | Preventive retinal detachment treatment by heat or laser, 1 or more sessions | 13 | $6.4K | $490.28 | 2.69x |
| 76512 | Ultrasound of eye disease, growth, or structure | 138 | $6.0K | $43.18 | 6.08x |
This provider submits charges 4.31 times higher than what Medicare actually pays.
A markup ratio of 4.31x means for every $100 Medicare pays, this provider initially charges $431. This is higher than the national average.
Always verify provider credentials and location before scheduling appointments. This data reflects Medicare payments and may not include all practice locations.
Share this provider's Medicare payment information
Last Updated: February 2026 (data through 2023, the latest CMS release)
Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.
Believe this data is inaccurate? Dispute this data